Assay News and Research

RSS

New immuno-assay can detect small molecules with 50-fold greater sensitivity

As medical science has come to understand that the human body is controlled on the molecular level by various proteins, hormones, drugs, and other substances, technologies have developed to detect levels of these molecules in order to monitor health and diagnose disease.

6 Dec 2018

New method could lead to better understanding of complex interactions between human gut microbes

The gut microbiome -- the world of microbes that inhabit the human intestinal tract -- has captured the interest of scientists and clinicians for its critical role in health.

6 Dec 2018

From Our Bench to Yours: Antibody Advice from Proteintech

An interview with Dr. Karolina Szczesna, discussing the tell-tale signs of a good antibody and how Proteintech are working to improve experimental results for scientists.

From Proteintech Group, Inc 5 Dec 2018

Cancer DNA signature will revolutionize point-of-care diagnostics

Researchers have developed a potentially game-changing new technology that could revolutionize cancer point-of-care (POC) diagnostics.

4 Dec 2018

Asuragen launches assay to help diagnose Steinert’s Disease

Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced the CE marking and launch of the AmplideX DM1 Dx Kit, which simplifies the analysis of repeat expansions within the DMPK gene and is intended to aid in the diagnosis of Myotonic Dystrophy Type I (DM1), also known as Steinert's Disease.

4 Dec 2018

The Native Antigen Company launches ground-breaking Zika virus immunoassays

The Native Antigen Company has launched a series of ground-breaking immunoassays for Zika virus, offering researchers in academia, public health and drug discovery the capability to work with unprecedented levels of specificity and sensitivity.

29 Nov 2018

New York State approves NYGC's Whole Genome and Transcriptome Sequencing for oncology

The New York Genome Center has received approval from the New York State Department of Health to offer whole genome and RNA transcriptome sequencing in its Clinical Laboratory Evaluation Program-certified laboratory.

29 Nov 2018

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

One of the most successful techniques to combat multidrug resistance in cancer cells is the downregulation of those genes responsible for drug resistance.

22 Nov 2018

Researchers have trained a computer to analyze breast cancer images and classify tumors

Using technology similar to the type that powers facial and speech recognition on a smartphone, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have trained a computer to analyze breast cancer images and then classify the tumors with high accuracy.

19 Nov 2018

Forming 3D Neuronal Models of the Brain

In this interview, conducted at SfN 2018, Grischa Chandy from Molecular Devices provides insight on 3D imaging solutions for neuroscience research.

From Molecular Devices, LLC 19 Nov 2018

Automating Data Capture and Image Analysis in Continuous Experiments

An interview with Lindy O’Clair, discussing the challenges of studying neuronal systems over time, and the development of an automated platform by Sartorius.

From Sartorius 19 Nov 2018

FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings

The Foundation for Innovative New Diagnostics today announced awards to support the development, manufacture and feasibility testing of two prototype hepatitis C virus core antigen immunoassays for confirmatory HCV diagnosis at the point of care.

16 Nov 2018

Drug used to treat dizziness may slow down growth of triple-negative breast cancer

Screening Food and Drug Administration approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in an animal model of the disease.

16 Nov 2018

Salk researchers report new methods to identify AD drug candidates with anti-aging properties

Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds.

14 Nov 2018

The Human Mini Heart-in-a-Jar That Could One Day Replace Animal Testing

An interview with Dr. Kevin Costa, discussing the miniaturized heart-in-a-jar model developed by Novoheart, and its applications in personalized medicine.

12 Nov 2018

Studying sensory neurons could provide new insights to treat ALS

Virginia Tech Carilion Research Institute scientists have shown that mutations in specific genes that destroy motor neurons and thereby cause the devastating effects of amyotrophic lateral sclerosis-- also known as ALS or Lou Gehrig's disease -- also attack sensory neurons.

9 Nov 2018

InDevR's new VaxArray to improve potency testing for measles and rubella vaccines

InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.

8 Nov 2018

Researchers find no link between childhood vaccination and risk of allergy

Researchers at Karolinska Institutet in Sweden, having compared the development of allergies in children with and without the recommended vaccinations, find no support for the claim that childhood vaccination can increase the risk of allergy.

7 Nov 2018

Horizon Discovery collaborates with Biocartis to offer reference standards for new Idylla MSI assay

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announces that it has developed a set of precisely defined cell line-derived reference standards to support Biocartis’ recently launched Idylla™ microsatellite instability Assay.

From Revvity 5 Nov 2018

SYNENTEC's new automated cell imager offers increased throughput, high quality images

SYNENTEC GmbH, the German manufacturer of automated cell imagers, has launched its latest generation of CELLAVISTA imagers: CELLAVISTA 4.

1 Nov 2018